Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Friedman

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
JAMA|March 23, 2001
Orthostatic hypotension and chronic fatigue syndromeT C Friedman, D Echeverry, R E Poland
Molecular and Cellular Endocrinology|January 12, 2000
Regulation of prohormone convertase 1 (PC1) by gp130-related cytokinesQ L Li, E Jansen, T C Friedman
Endocrinology|February 1, 1986
Evidence for regulation of a thyrotropin-releasing hormone degradation pathway in GH3 cellsT C Friedman, T F Davies, S Wilk
JAMA|June 1, 1999
Low-dose hydrocortisone for chronic fatigue syndromeT C Friedman, A Adesanya, R E Poland
Biochemical and Biophysical Research Communications|July 31, 1985
Pyroglutamyl diazomethyl ketone: potent inhibitor of mammalian pyroglutamyl peptide hydrolaseS Wilk, T C Friedman, T B Kline
Biochemistry|July 16, 1985
5-Oxoprolinal: transition-state aldehyde inhibitor of pyroglutamyl-peptide hydrolaseT C Friedman, T B Kline, S Wilk
Endocrinology|September 1, 1994
In vitro processing of proopiomelanocortin by recombinant PC1 (SPC3)T C Friedman, Y P Loh, N P Birch
Endocrinology|December 1, 1993
Generation of 1-37 and 1-38 forms of adrenocorticotropin by mono- and dipeptidyl serine carboxypeptidase activities in bovine pituitary secretory vesiclesT C Friedman, H C Chen, Y P Loh
Regulatory Peptides|December 4, 2001
Up-regulation of splenic prohormone convertases PC1 and PC2 in diabetic ratsM Nakashima, Y Nie, Q L Li, et al.
Acta Neurochirurgica. Supplement|January 1, 1997
Enhanced brain opioid receptor activity precedes blood-brain barrier disruptionP Ting, P A Cushenberry, T C Friedman, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
JAMA|March 23, 2001
Orthostatic hypotension and chronic fatigue syndromeT C Friedman, D Echeverry, R E Poland
Molecular and Cellular Endocrinology|January 12, 2000
Regulation of prohormone convertase 1 (PC1) by gp130-related cytokinesQ L Li, E Jansen, T C Friedman
Endocrinology|February 1, 1986
Evidence for regulation of a thyrotropin-releasing hormone degradation pathway in GH3 cellsT C Friedman, T F Davies, S Wilk
JAMA|June 1, 1999
Low-dose hydrocortisone for chronic fatigue syndromeT C Friedman, A Adesanya, R E Poland
Biochemical and Biophysical Research Communications|July 31, 1985
Pyroglutamyl diazomethyl ketone: potent inhibitor of mammalian pyroglutamyl peptide hydrolaseS Wilk, T C Friedman, T B Kline
Biochemistry|July 16, 1985
5-Oxoprolinal: transition-state aldehyde inhibitor of pyroglutamyl-peptide hydrolaseT C Friedman, T B Kline, S Wilk
Endocrinology|September 1, 1994
In vitro processing of proopiomelanocortin by recombinant PC1 (SPC3)T C Friedman, Y P Loh, N P Birch
Endocrinology|December 1, 1993
Generation of 1-37 and 1-38 forms of adrenocorticotropin by mono- and dipeptidyl serine carboxypeptidase activities in bovine pituitary secretory vesiclesT C Friedman, H C Chen, Y P Loh
Regulatory Peptides|December 4, 2001
Up-regulation of splenic prohormone convertases PC1 and PC2 in diabetic ratsM Nakashima, Y Nie, Q L Li, et al.
Acta Neurochirurgica. Supplement|January 1, 1997
Enhanced brain opioid receptor activity precedes blood-brain barrier disruptionP Ting, P A Cushenberry, T C Friedman, et al.
Pageof 8